Difference between revisions of "SUIT-004"
From Bioblast
Line 2: | Line 2: | ||
|abbr=RP1-short | |abbr=RP1-short | ||
|description=[[File:1PM;2D;3U;4S;5Rot.png|450px]] | |description=[[File:1PM;2D;3U;4S;5Rot.png|450px]] | ||
|info= | |info= | ||
}} | }} | ||
::: | :::: [[SUIT protocol pattern]]: 1PM;2D;3U;4S;5Rot- | ||
The SUIT-004 protocols are designed to provide a quick assessment of the linear coupling control ([[LEAK-respiration|''L'']]-[[Oxidative phosphorylation| ''P'']]-[[ET-capacity| ''E'']]) with NADH-linked substrates ([[PM pathway control state|PM]]) and the contribution of the [[S-pathway control state| S-pathway]] to the ET state ([[NADH_Electron_transfer-pathway_state|N]], [[NS-pathway control state| NS]], [[Succinate pathway control state| S]]). SUIT-004 can be extended with the CIV assay module. | The SUIT-004 protocols are designed to provide a quick assessment of the linear coupling control ([[LEAK-respiration|''L'']]-[[Oxidative phosphorylation| ''P'']]-[[ET-capacity| ''E'']]) with NADH-linked substrates ([[PM pathway control state|PM]]) and the contribution of the [[S-pathway control state| S-pathway]] to the ET state ([[NADH_Electron_transfer-pathway_state|N]], [[NS-pathway control state| NS]], [[Succinate pathway control state| S]]). SUIT-004 can be extended with the CIV assay module. | ||
__TOC__ | __TOC__ | ||
Communicated by [[Doerrier C]], [[Iglesias-Gonzalez J]], [[Krumschnabel G]] | Communicated by [[Doerrier C]], [[Iglesias-Gonzalez J]], [[Krumschnabel G]], [[Gnaiger E]] (last update 2019-06-07) | ||
== Specific SUIT protocols == | == Specific SUIT protocols == |
Revision as of 18:38, 7 June 2019
Description
Abbreviation: RP1-short
- SUIT protocol pattern: 1PM;2D;3U;4S;5Rot-
The SUIT-004 protocols are designed to provide a quick assessment of the linear coupling control (L- P- E) with NADH-linked substrates (PM) and the contribution of the S-pathway to the ET state (N, NS, S). SUIT-004 can be extended with the CIV assay module.
Communicated by Doerrier C, Iglesias-Gonzalez J, Krumschnabel G, Gnaiger E (last update 2019-06-07)
Specific SUIT protocols
- SUIT-004 O2 pfi D010 for permeabilized fibers
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1PM | PML(n) | N | CI | 1PM
|
2D | PMP | N | CI | 1PM;2D
|
2c | PMcP | N | CI | 1PM;2D;2c
|
3U | PME | N | CI | 1PM;2D;3U
|
4S | PMSE | NS | CI&II | 1PM;2D;3U;4S
|
5Rot | SE | S | CII | 1PM;2D;3U;4S;5Rot
|
6Ama | ROX | 1PM;2D;3U;4S;5Rot;6Ama
|
Step | Respiratory state | Pathway control | ET-Complex | Comment |
---|---|---|---|---|
## AsTm | AsTmE | CIV | CIV | |
## Azd | CHB |
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- Main fuel substrates
- » Glutamate, G
- » Glycerophosphate, Gp
- » Malate, M
- » Octanoylcarnitine, Oct
- » Pyruvate, P
- » Succinate, S
- Main fuel substrates
- Glossary
Strengths and limitations
- A succinate concentration of >10 mM may be required for saturating SE capacity.
- + Linear coupling control (L- P- E) with N substrates (PM).
- + Pathway control in ET state (N, NS, S).
- + This protocol can be extended with the Complex IV module.
- + Short experimental time.
- - The substrate combination for maximum ET capacity (FNSGP) is not assayed in SUIT-004 in favour of reducing the experimental time.
Compare SUIT protocols
- SUIT-001 (RP1): SUIT-004 is a shortened version of RP1; without G, F and Gp.
References
MitoPedia concepts: MiP concept, SUIT protocol, Recommended
MitoPedia methods:
Respirometry